Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Clinical features and molecular analysis of arginine-vasopressin neurophysin II gene in long-term follow-up patients with idiopathic central diabetes insipidus

Full text
Author(s):
Batista, Sergio L. [1] ; Moreira, Ayrton C. ; Antunes-Rodrigues, Jose [1] ; de Castro, Margaret ; Elias, Lucila L. K. [1] ; Elias, Paula C. L. [2]
Total Authors: 6
Affiliation:
[1] USP, Fac Med Ribeirao Preto, Dept Fisiol, BR-14049900 Ribeirao Preto, SP - Brazil
[2] USP, Fac Med Ribeirao Preto, Dept Clin Med, Div Endocrinol, BR-14049900 Ribeirao Preto, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: Arquivos Brasileiros de Endocrinologia e Metabologia; v. 54, n. 3, p. 269-273, APR 2010.
Web of Science Citations: 7
Abstract

Introduction: Central diabetes insipidus {[}D1) characterized by polyuria, polydipsia and inability to concentrate urine, has different etiologies including genetic, autoimmune, post-traumatic, among other causes. Autosomal dominant central DI presents the clinical feature of a progressive decline of arginine-vasopressin (AVP) secretion. Objective: In this study, we characterized the clinical features and sequenced the AVP-NPII gene of seven long-term follow-up patients with idiopathic central DI in an attempt to determine whether a genetic cause would be involved. Methods: The diagnosis of central DI was established by fluid deprivation test and hypertonic saline infusion. For molecular analysis, genomic DNA was extracted and the AVP-NPII gene was amplified by polymerase chain reaction and sequenced. Results: Sequencing analysis revealed a homozygous guanine insertion in the intron 2 (IVS2 +28 InsG) of the AVP-NPII gene in four patients, which represents an alternative gene assembly. No mutation in the code region of the AVP-NPII gene was found. Conclusions: The homozygous guanine insertion in intron 2 (IV52 +28 InsG) is unlikely to contribute to the AVP-NPII gene modulation in DI. In addition, the etiology of idiopathic central DI in children may not be apparent even after long-term follow-up, and requires continuous etiological surveillance. Arq Bras Endocrinol Metab. 2010;54(3):269-73 (AU)